| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
478 |
431 |
$6K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,087 |
1,037 |
$4K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
329 |
319 |
$3K |
| G9622 |
Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method |
608 |
585 |
$3K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
329 |
322 |
$3K |
| 93000 |
|
177 |
171 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
245 |
240 |
$2K |
| 90674 |
|
69 |
69 |
$1K |
| 3074F |
|
501 |
472 |
$972.55 |
| 3078F |
|
451 |
420 |
$897.56 |
| G0270 |
Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes |
764 |
684 |
$749.41 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
607 |
542 |
$587.67 |
| 90658 |
|
76 |
76 |
$502.68 |
| H0001 |
Alcohol and/or drug assessment |
658 |
629 |
$430.00 |
| 90756 |
|
40 |
40 |
$407.44 |
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
19 |
18 |
$345.24 |
| 99497 |
|
15 |
15 |
$275.61 |
| 1126F |
|
363 |
336 |
$75.00 |
| 1160F |
|
395 |
383 |
$63.00 |
| G0008 |
Administration of influenza virus vaccine |
40 |
40 |
$55.00 |
| 36415 |
Collection of venous blood by venipuncture |
610 |
568 |
$49.20 |
| 3079F |
|
27 |
27 |
$45.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
379 |
373 |
$40.03 |
| 1159F |
|
211 |
208 |
$40.00 |
| 99408 |
|
18 |
12 |
$36.10 |
| 97802 |
|
262 |
234 |
$27.24 |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
335 |
329 |
$15.00 |
| G0435 |
Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening |
310 |
305 |
$10.00 |
| G0432 |
Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening |
370 |
360 |
$10.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
112 |
101 |
$5.01 |
| 82272 |
|
169 |
154 |
$3.38 |
| 3008F |
|
554 |
523 |
$0.09 |
| 2022F |
|
15 |
13 |
$0.02 |
| 3016F |
|
310 |
296 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
986 |
912 |
$0.00 |
| G8731 |
Pain assessment using a standardized tool is documented as negative, no follow-up plan required |
583 |
531 |
$0.00 |
| 1033F |
|
269 |
258 |
$0.00 |
| G9820 |
Documentation of a chlamydia screening test with proper follow-up |
327 |
318 |
$0.00 |
| G2010 |
Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment |
334 |
329 |
$0.00 |
| G9383 |
Patient received screening for hcv infection within the 12 month reporting period |
323 |
315 |
$0.00 |
| G9507 |
Documentation that the patient is on a statin medication or has documentation of a valid contraindication or exception to statin medications; contraindications/exceptions that can be defined by diagnosis codes include pregnancy during the measurement period, active liver disease, rhabdomyolysis, end stage renal disease on dialysis and heart failure; provider documented contraindications/exceptions include breastfeeding during the measurement period, woman of child-bearing age not actively taking birth control, allergy to statin, drug interaction (hiv protease inhibitors, nefazodone, cyclosporine, gemfibrozil, and danazol) and intolerance (with supporting documentation of trying a statin at least once within the last 5 years or diagnosis codes for myostitis or toxic myopathy related to drugs) |
127 |
124 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
13 |
13 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
76 |
76 |
$0.00 |
| 3725F |
|
367 |
344 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
28 |
28 |
$0.00 |
| G8935 |
Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy |
12 |
12 |
$0.00 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
27 |
27 |
$0.00 |
| 4013F |
|
29 |
26 |
$0.00 |
| G0271 |
Medical nutrition therapy, reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition, or treatment regimen (including additional hours needed for renal disease), group (2 or more individuals), each 30 minutes |
252 |
225 |
$0.00 |
| G9150 |
National committee for quality assurance - level 3 medical home |
273 |
261 |
$0.00 |
| 90461 |
|
12 |
12 |
$0.00 |
| 4274F |
|
54 |
54 |
$0.00 |
| 1158F |
|
36 |
33 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
132 |
115 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
13 |
12 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
1,064 |
976 |
$0.00 |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
25 |
25 |
$0.00 |
| 94760 |
|
1,115 |
1,019 |
$0.00 |
| 1000F |
|
309 |
294 |
$0.00 |
| 1220F |
|
199 |
186 |
$0.00 |
| 82270 |
|
165 |
152 |
$0.00 |
| 1036F |
|
271 |
260 |
$0.00 |
| 4293F |
|
68 |
66 |
$0.00 |
| H0002 |
Behavioral health screening to determine eligibility for admission to treatment program |
635 |
606 |
$0.00 |
| 36410 |
|
15 |
15 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
376 |
347 |
$0.00 |
| 99422 |
|
70 |
70 |
$0.00 |
| 1123F |
|
49 |
45 |
$0.00 |
| 3014F |
|
15 |
12 |
$0.00 |
| G9664 |
Patients who are currently statin therapy users or received an order (prescription) for statin therapy |
13 |
13 |
$0.00 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
53 |
50 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
27 |
27 |
$0.00 |
| S0257 |
Counseling and discussion regarding advance directives or end of life care planning and decisions, with patient and/or surrogate (list separately in addition to code for appropriate evaluation and management service) |
15 |
15 |
$0.00 |